Utpal Koppikar's Insider Trades & SAST Disclosures
Utpal Koppikar's most recent trade in C4 Therapeutics Inc was a trade of 32,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Utpal Koppikar.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| C4 Therapeutics Inc | Utpal Koppikar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Utpal Koppikar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.63 per share. | 02 Mar 2023 | 6,871 | 181,978 (0%) | 0% | 3.6 | 24,921 | Common Stock |
| C4 Therapeutics Inc | Utpal Koppikar | Director | Purchase of securities on an exchange or from another person at price $ 5.60 per share. | 08 Feb 2023 | 5,667 | 5,667 | - | 5.6 | 31,735 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.46 per share. | 07 Feb 2023 | 2,485 | 188,849 (0%) | 0% | 5.5 | 13,568 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.04 per share. | 16 Aug 2022 | 5,940 | 197,589 (0%) | 0% | 5.0 | 29,908 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.63 per share. | 08 Jun 2022 | 5,853 | 203,529 (0%) | 0% | 5.6 | 32,952 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.32 per share. | 17 May 2022 | 4,616 | 208,558 (0%) | 0% | 5.3 | 24,539 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.32 per share. | 17 May 2022 | 966 | 207,592 (0%) | 0% | 5.3 | 5,136 | Common Stock |
| C4 Therapeutics Inc | Utpal Koppikar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 41,200 | 41,200 | - | - | Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 115,107 | 115,107 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 61,235 | 216,937 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.86 per share. | 01 Mar 2022 | 2,272 | 214,665 (0%) | 0% | 9.9 | 22,393 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.86 per share. | 01 Mar 2022 | 1,491 | 213,174 (0%) | 0% | 9.9 | 14,697 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.46 per share. | 07 Feb 2022 | 2,496 | 155,702 (0%) | 0% | 14.5 | 36,096 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.12 per share. | 16 Nov 2021 | 3,655 | 157,714 (0%) | 0% | 17.1 | 62,562 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 17 Aug 2021 | 3,579 | 161,369 (0%) | 0% | 12.5 | 44,852 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.06 per share. | 08 Jun 2021 | 5,820 | 164,948 (0%) | 0% | 14.1 | 81,829 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.55 per share. | 18 May 2021 | 3,616 | 168,966 (0%) | 0% | 14.6 | 52,613 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 26 Mar 2021 | 1,761 | 172,582 (0%) | 0% | 14.6 | 25,675 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.74 per share. | 02 Mar 2021 | 1,461 | 174,343 (0%) | 0% | 16.7 | 24,457 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 68,314 | 68,314 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 45,258 | 175,804 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.39 per share. | 08 Feb 2021 | 1,759 | 130,546 (0%) | 0% | 20.4 | 35,866 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.77 per share. | 17 Nov 2020 | 1,469 | 132,061 (0%) | 0% | 19.8 | 29,048 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.09 per share. | 18 Aug 2020 | 1,496 | 133,530 (0%) | 0% | 12.1 | 18,087 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.18 per share. | 09 Jun 2020 | 3,924 | 135,026 (0%) | 0% | 10.2 | 39,946 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.22 per share. | 18 May 2020 | 1,428 | 137,375 (0%) | 0% | 11.2 | 16,022 | Common Stock |
| Atara Biotherapeutics Inc | Utpal Koppikar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.17 per share. | 27 Mar 2020 | 1,827 | 137,330 (0%) | 0% | 9.2 | 16,754 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges